Neuroprotective Effect of TAK-937, a Novel Cannabinoid Receptor Agonist, in Rat Permanent and Thrombotic Middle Cerebral Artery Occlusion Models

被引：0
|
作者：
Murakami, Koji [1 ]
Suzuki, Motohisa [1 ]
Suzuki, Noriko [1 ]
Hamajo, Kazuhiro [1 ]
Tsukamoto, Tetsuya [1 ]
Shimojo, Masato [1 ]
机构：
[1] Takeda Pharmaceut Co Ltd, Osaka, Japan
来源：
STROKE | 2011年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E212 / E212
页数：1
相关论文
共 50 条
  • [1] Neuroprotective Effect of TAK-937, a Novel Cannabinoid Receptor Agonist, in a Rat Transient Middle Cerebral Artery Occlusion Model
    Suzuki, Noriko
    Suzuki, Motohisa
    Hamajo, Kazuhiro
    Murakami, Koji
    Tsukamoto, Tetsuya
    Shimojo, Masato
    STROKE, 2011, 42 (03) : E213 - E213
  • [2] Neuroprotective Effect of TAK-937, a Novel Cannabinoid Receptor Agonist, in a Nonhuman Primate Thromboembolic Stroke Model
    Suzuki, Motohisa
    Hamajo, Kazuhiro
    Suzuki, Noriko
    Murakami, Koji
    Tsukamoto, Tetsuya
    Shimojo, Masato
    STROKE, 2011, 42 (03) : E298 - E299
  • [3] Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates
    Suzuki, Noriko
    Suzuki, Motohisa
    Murakami, Koji
    Hamajo, Kazuhiro
    Tsukamo, Tetsuya
    Shimojo, Masato
    BRAIN RESEARCH, 2012, 1430 : 93 - 100
  • [4] Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window, combination with t-PA and efficacy in aged rats
    Murakami, Koji
    Suzuki, Motohisa
    Suzuki, Noriko
    Hamajo, Kazuhiro
    Tsukamoto, Tetsuya
    Shimojo, Masato
    BRAIN RESEARCH, 2013, 1526 : 84 - 93
  • [5] Contribution of Hypothermia and CB1 Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model
    Suzuki, Noriko
    Suzuki, Motohisa
    Hamajo, Kazuhiro
    Murakami, Koji
    Tsukamoto, Tetsuya
    Shimojo, Masato
    PLOS ONE, 2012, 7 (07):
  • [6] Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion
    Cifuentes, Enrique G.
    Hornick, Mary G.
    Havalad, Suresh
    Donovan, Ramona L.
    Gulati, Anil
    FRONTIERS IN PEDIATRICS, 2018, 6
  • [7] Neuroprotective effect of Longshengzhi capsule following permanent middle cerebral artery occlusion in rats
    Xiaoli Sun
    Shuzhen Guo
    Yong Wang
    Bangze Fu
    Junjie Liu
    Yili Zhang
    Ruocong Yang
    Chun Li
    Jian Gao
    Li Gao
    Wei Wang
    JournalofTraditionalChineseMedicalSciences, 2020, 7 (01) : 12 - 19
  • [8] Neuroprotective effect of ligustilide on middle cerebral artery occlusion in rats
    Li, GS
    Tian, JW
    ANNALS OF NEUROLOGY, 2005, 58 : S10 - S10
  • [9] Neuroprotective effect of interleukin-1 receptor antagonist following permanent middle cerebral artery occlusion is mediated by resident microglia
    Clausen, Bettina Hjelm
    Lambertsen, Kate Lykke
    Babcock, Alicia
    Dagnaes-Hansen, Frederik
    Finsen, Bente
    NEURON GLIA BIOLOGY, 2007, 2 : S159 - S160
  • [10] Pathological Comparisons of the Hippocampal Changes in the Transient and Permanent Middle Cerebral Artery Occlusion Rat Models
    Shah, Fawad Ali
    Li, Tao
    Al Kury, Lina Tariq
    Zeb, Alam
    Khatoon, Shehla
    Liu, Gongping
    Yang, Xifei
    Liu, Fang
    Yao, Huo
    Khan, Arif-Ullah
    Koh, Phil Ok
    Jiang, Yuhua
    Li, Shupeng
    FRONTIERS IN NEUROLOGY, 2019, 10
12345